In line with the recognized proliferative role of ERα in ovarian cancer [8], our in vitro results actually confirmed that ERα expression is necessary and sufficient to induce the growth of HGSOC cells following estrogen treatment, since only the ERα-positive PEO1 cell line was growth-stimulated by E2 and PPT. The gene discussed is ESR1; the disease is ovarian cancer.